Resources

2020

Advice on the changes to the PCV13 immunization schedule

2020 ∙ Conseil Supérieur de la Santé (CSS)

Pneumococcal vaccination for adults

2020 ∙ Haute Autorité de Santé

Pneumococcal vaccination in the context of supply issues and the COVID-19 epidemic in France

2019 ∙ McGirr, A. Iqbal, S. M. Izurieta, P. Talarico, C. Luijken, J. Redig, J. Newson, R. S.

A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines

2019 ∙ Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.

Cost-effectiveness of adult vaccinations: A systematic review

2019 ∙ Sings, H. L. De Wals, P. Gessner, B. D. Isturiz, R. Laferriere, C. McLaughlin, J. M. Pelton, S. Schmitt, H. J. Suaya, J. A. Jodar, L.

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies

2019 ∙ Vardanjani, H. M. Borna, H. Ahmadi, A.

Effectiveness of pneumococcal conjugate vaccination against invasive pneumococcal disease among children with and those without HIV infection: a systematic review and meta-analysis

2019 ∙ Ngocho, J. S. Magoma, B. Olomi, G. A. Mahande, M. J. Msuya, S. E. de Jonge, M. I. Mmbaga, B. T.

Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review

2019 ∙ Adawi, M. Bragazzi, N. L. McGonagle, D. Watad, S. Mahroum, N. Damiani, G. Conic, R. Bridgewood, C. Mahagna, H. Giacomelli, L. Eggenhoffner, R. Mahamid, M. Pigatto, P. D. M. Amital, H. Watad, A.

Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis

2019 ∙ Vadlamudi, N. K. Chen, A. Marra, F.

306 results found